Andrew Edwin Grulich

Professor Andrew Grulich is an epidemiologist specializing in HIV/STI prevention and cancer epidemiology at UNSW Sydney's Kirby Institute. His research focuses on biomedical HIV prevention strategies, particularly pre-exposure prophylaxis (PrEP) implementation, and the epidemiology of HPV-related cancers in immunocompromised populations. He leads large-scale studies on anal cancer screening and prevention among high-risk groups.

His key research areas include:

• HIV transmission dynamics
• PrEP effectiveness and adherence
• HPV vaccination impact
• Anal cancer screening methods
• STI epidemiology in gay and bisexual men

Professor Grulich has led numerous national studies including the EPIC-NSW trial on PrEP implementation and the SPANC study on anal cancer prevention. His work informs public health policies for HIV/STI control in Australia and internationally.